Edward B De Vol
Overview
Explore the profile of Edward B De Vol including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
221
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saeed B, ALbalawi A, Bintalib M, Alturki A, De Vol E, ALzayed B, et al.
J Clin Med
. 2025 Feb;
14(3).
PMID: 39941415
The data about pregnancy while having a low ejection fraction are scarce, since pregnancy is not recommended for women with an ejection fraction of less than 30%. There is an...
2.
Alsayer R, De Vol E, AlMeharish A, AlFattani A, Alghamdi A, AlBehlal L, et al.
Breast Cancer (Dove Med Press)
. 2024 Sep;
16:545-554.
PMID: 39246673
Purpose: Breast cancer is the most common cancer among women in the Saudi Arabia, and over 50% of the cases are detected at a late stage. This study aimed to...
3.
Alkuraya I, De Vol E
Stem Cell Reports
. 2024 Jul;
19(8):1043-1047.
PMID: 38996491
The effect of consanguinity on identifying universal induced pluripotent stem cell (iPSC) donors, i.e., homozygous for the major human leukocyte antigen (HLA) loci, is unknown. The discovery sample size was...
4.
Abdulqawi R, Alawwami M, Aldosari O, Aldosari Z, Alhuqbani M, Saleh R, et al.
Clin Transplant
. 2024 Jul;
38(7):e15374.
PMID: 38979724
Background: The lack of evidence regarding optimal desensitization strategies for lung transplant candidates with preformed donor specific anti-human leukocyte antigen antibodies (DSAs) has led to varying approaches among centers towards...
5.
Al-Saud B, AlRumayyan N, AlFattani A, Awwad S, Al Saud D, Mohammed R, et al.
J Clin Immunol
. 2023 May;
43(6):1360-1366.
PMID: 37145392
Background And Aims: Subcutaneous immunoglobulin (SCIG) home infusion is widely used as an alternative to intravenous immunoglobulin (IVIG). This study aimed to determine the quality of life (QoL) of patients...
6.
Alghamdi I, Almadi M, Alsohaibani F, Mosli M, De Vol E, Abaalkhail F, et al.
Clin Exp Gastroenterol
. 2021 Feb;
14:45-57.
PMID: 33603433
Purpose: Over the last decades, the incidence of pancreatic cancer has increased, particularly in countries with a higher socioeconomic status. The present work aimed to provide detailed epidemiological data on...
7.
Al-Jazairi A, Raslan S, Al-Mehizia R, Al Dalaty H, De Vol E, Saad E, et al.
Ann Pharmacother
. 2020 Sep;
55(5):592-604.
PMID: 32959678
Background: The use of extracorporeal membrane oxygenator (ECMO) support devices are associated with complications, including bleeding and thrombosis. Unfractionated heparin (UFH) is the gold standard anticoagulant in ECMO patients. Clinically,...
8.
Bazarbashi S, De Vol E, Maraiki F, Al-Jedai A, Ali A, Alhammad A, et al.
Pharmacoecon Open
. 2020 Apr;
4(4):625-633.
PMID: 32291726
Background: No willingness-to-pay (WTP) per quality-adjusted life-year (QALY) value exists for the Kingdom of Saudi Arabia (KSA). Objective: The primary objective of this study was to determine the WTP for...
9.
Alzahrani H, Almalag H, AlRuthia Y, Al-Hussain F, Balkhi B, Almutairi L, et al.
Neuropsychiatr Dis Treat
. 2019 Oct;
15:2781-2788.
PMID: 31576133
Background: Antiepileptic drug monotherapy is the mainstay of treatment for epilepsy; however, the efficacy of different antiepileptic drugs in reducing the incidence of seizure-related hospitalization among older adults, who are...
10.
Al-Jazairi A, Al Alshaykh H, Di Salvo G, De Vol E, AlHalees Z
Ann Pharmacother
. 2019 Feb;
53(8):786-793.
PMID: 30788973
The current CHEST guidelines recommend the use of antithrombotic therapy, either aspirin or warfarin, as a primary thromboembolic complications (TECs) prophylaxis in patients who undergo Fontan procedure, without specification on...